TY  - JOUR
AU  - Aparicio Serrano, Ana
AU  - Gallego Jimenez, Elma
AU  - Castro Rodriguez, Javier
AU  - Soto Escribano, Pilar
AU  - Iglesias Flores, Eva
AU  - Marin Pedrosa, Sandra
AU  - Benitez, Jose Manuel
PY  - 2022
DO  - 10.17235/reed.2022.8635/2021
SN  - 1130-0108
UR  - http://hdl.handle.net/10668/21728
T2  - Revista espanola de enfermedades digestivas
AB  - Mesalazine is the most widely used aminosalicylate for induction and maintenance of remission in patients with mild-to-moderate ulcerative colitis (UC). Drug-induced hypersensitivity pneumonitis is considered very rare (< 1/10 000 patients).
LA  - en
PB  - Sociedad Espanola de Patologia Digestiva
KW  - Mesalazine
KW  - Lung injury
KW  - Ulcerative colitis
KW  - Anti-inflammatory agents, non-steroidal
KW  - COVID-19
KW  - Colitis, ulcerative
KW  - Humans
KW  - Lung diseases, interstitial
KW  - Mesalamine
TI  - Mesalazine induced interstitial pneumonitis in the COVID era.
TY  - research article
VL  - 114
ER  -